Your browser doesn't support javascript.
loading
SPARC is down-regulated by DNA methylation and functions as a tumor suppressor in T-cell lymphoma.
Yan, Jiaqin; Zhang, Junhui; Zhang, Xudong; Li, Xin; Li, Ling; Li, Zhaoming; Chen, Renyin; Zhang, Lei; Wu, Jingjing; Wang, Xinhua; Sun, Zhenchang; Fu, Xiaorui; Chang, Yu; Nan, Feifei; Yu, Hui; Wu, Xiaolong; Feng, Xiaoyan; Li, Wencai; Zhang, Mingzhi.
Affiliation
  • Yan J; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Zhang J; Department of Otorhinolaryngology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Zhang X; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Li X; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Li L; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Li Z; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Chen R; Department of Pathology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Zhang L; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Wu J; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Wang X; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Sun Z; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Fu X; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Chang Y; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Nan F; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Yu H; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Wu X; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Feng X; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Li W; Department of Pathology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China.
  • Zhang M; Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, PR China. Electronic address: mingzhi_zhang@sohu.com.
Exp Cell Res ; 364(2): 125-132, 2018 03 15.
Article in En | MEDLINE | ID: mdl-29277504
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Down-Regulation / Osteonectin / Lymphoma, T-Cell / DNA Methylation Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Down-Regulation / Osteonectin / Lymphoma, T-Cell / DNA Methylation Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Year: 2018 Type: Article